No Prescription |
 |
 | ||
|
AQWET SPRAY SALIVA SUPPLEMENT |
|
| ||
No Prescription » Prescription Drugs 2 » AQWET SPRAY SALIVA SUPPLEMENT Composition Sodium Carboxymethylcellulose 1.00 % w/w Sorbitol (as Sorbitol solution IP) 3.00 % w/w Potassium chloride IP 0.12 % w/w Sodium chloride IP 0.0844 % w/w Magnesium chloride IP 0.0052 % w/w Calcium chloride IP 0.0146 % w/w Potassium dihydrogen phosphate BP 0.0342 % w/w Description Aqwet is synthetic saliva. It is available as an aerosol spray in natural flavour. The volume contained in each aerosol can is 50 ml. It moistens the mucosa of the mouth tongue and throat. It can be used as a replacement for natural saliva. It is more effective and long lasting than drinking or wetting the mouth with water or glycerol. Aqwet is an ozone freindly. Indications Aqwet can be used for dryness of the mouth or throat regardless of whether the condition is temporary or permanent. It is also used for intensive hygiene of the oral cavity and to help relieve bad taste. Dosage And Administration The can should always be held upright with the valve opening directed towards the mouth or throat. The nozzle should be pushed down for 1 to 2 seconds. Aqwet can be used as often as needed to maintain moistness. The valve opening should be cleaned if it becomes blocked. Buy AQWET SPRAY SALIVA SUPPLEMENT and other Prescription Drugs 2 products online at Medstore. 4843
About AQWET SPRAY SALIVA SUPPLEMENT: Product Type: Prescription Drugs 2 AQWET SPRAY ( SALIVA SUPPLEMENT GENERIC SALIVA SUPPLEMENT ) AQWET SPRAY (SALIVA SUPPLEMENT GENERIC SALIVA SUPPLEMENT) SALIVA SUPPLEMENT GENERIC SALIVA SUPPLEMENT 50ML 500 Sprays SALIVA SUPPLEMENT GENERIC SALIVA SUPPLEMENT AQWET SPRAY
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
